Vipoglanstat hydrogensulfate

N/A

Report date: 2026/04/18 20:00:19
NME

Base Information

Drug NameVipoglanstat hydrogensulfate
Drug Alias NameBI-1029539GS-248
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin E synthase inhibitors
TargetsProstaglandin E synthase
Therapy Area/IndicationsScleroderma, SystemicEndometriosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[10] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOrexo Ab (Pulb)
China Registration ClassN/A

Develop Information

Active CompaniesGesynta Pharma Ab
Inactive CompaniesN/A
Active IndicationsScleroderma, SystemicEndometriosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank